ELI Beamlines: Fast track access for coronavirus-related research
ELI Beamlines, 12.05.2020
Czech Republic

The Extreme Light Infrastructure (ELI Beamlines) offers rapid access to the experimental cluster for advanced ultrafast optical spectroscopy and X-ray diffraction, to support the investigation of the SARS-CoV-2 virus characteristics and the development of possible vaccine and treatments. More information about the ELI Beamlines scientific cluster can be found here. Proposals and experiments will be supported by Research Programme 4 for Applications in Molecular, Bio-medical and Material Science, jointly with the ELIBIO Project teams. More information on available support (bio and bio-chemical) labs is available here.

CZECRIN: support for COVID-19 clinical studies
CZECRIN, 12.05.2020
Czech Republic

The Czech National Node to the European Clinical Research Infrastructure Network (CZECRIN) offers its support, services and expertise to all research-oriented physicians, with the aim of involving its forces in quick access to initiate national and especially transnational clinical trials. CZECRIN launched a dedicated website (available in Czech), to inform not only the professional, but also the non-expert public, about all ongoing and planned activities towards clinical research. Moreover, the NATIONAL CTUs NETWORK, a unit of CZECRIN, has been mapping the interest of healthcare facilities participating in the individual clinical trials focusing on the treatment of patients with the COVID-19 disease, which can be found on this website. In addition, the RI initiated the international study CZECRIN COVID-19, in collaboration with the Slovak SLOVACRIN network, aimed at evaluating the efficacy and safety of the combination of hydroxychloroquine and azithromycin in hospitalized patients with acute respiratory impairment requiring oxygen therapy. Furthermore, CZECRIN will offer research capacity and administrative support to other facilities to battle COVID-19.

GSI/FAIR researchers in the battle against COVID-19
GSI/FAIR, 12.05.2020

The GSI Helmholtzzentrum für Schwerionenforschung and the Facility for Antiproton and Ion Research (GSI/FAIR) develops innovative research strategies to support the fight against the current COVID-19 pandemic. The Biophysics Department plans to inactivate the virus with high-energy heavy ions in order to develop vaccines in cooperation with the Helmholtz Centre for Infection Research (HZI). In addition, the therapeutic effect of low-dose radiation against pneumonia caused by SARS-CoV-2 is currently being investigated. The Materials Research Department is working on membranes made of nanopores for improved and fast virus detection and for the development of tailored membranes for viral filtration masks.

ODISSEI: Research on COVID-19 social impact
ODISSEI, 24.04.2020
The Netherlands

The Open Data Infrastructure for Social Science and Economic Innovations Dutch (ODISSEI) brings together researchers with the necessary data, expertise and resources to conduct ground-breaking research and embrace the computational turn in social enquiry. In response to the COVID-19 pandemic, ODISSEI has granted two data proposals, by awarding time on the LISS data panel for corona-related research into home-schooling (Dr. Thijs Bol, University of Amsterdam) and the distribution of care responsibilities (Dr. Mara A. Yerkes, Utrecht University).

ELIXIR-CZ: Life science data services
ELIXIR-CZ, 23.04.2020
Czech Republic

The Czech National Infrastructure for Biological Data  (ELIXIR-CZ) provides a research infrastructure for the storage, processing and analysing data in the field of life sciences. ELIXIR-CZ has launched a website dedicated to COVID-19, where experts and the general public can find information on activities related to the fight against COVID-19. The website provides recommendations for data storage and sharing and the information on access to relevant data. ELIXIR-CZ specifically provides assistance in setting up the FAIR data principles, special software and analytics tools, and computing resources to help analyse data sets.

BSL3: Access to high containment lab facilities
BLS3, 23.04.2020
The Netherlands

The BSL3 in Rotterdam, was founded to accommodate safe research on infectious diseases, such as COVID-19. The BSL3 research lab facility in Rotterdam was designed to operate according to the highest international biosafety and biosecurity standards, and to facilitate research to multiple teams simultaneously, thus providing unique opportunities for collaborative COVID-19 research using a variety of research modalities including high end instruments for experiments and analyses, in vivo (animals) and in vitro.

CZ-OPENSCREEN: Coronavirus sample testing and database
CZ-OPENSCREEN, 20.04.2020
Czech Republic

The National Infrastructure for Chemical Biology (CZ-OPENSCREEN), Czech node to EU-OPENSCREEN ERIC, hosted by the Institute of Molecular Genetics of the Czech Academy of Sciences, plans to test up to 1,000 samples per day. CZ-OPENSCREEN focuses on the identification of new molecular probes and tools for research and validation of compounds suitable for the development of new drugs. The team has also developed the internal database CORONAbase, to register samples and to transform all the appropriate personal data to an electronic version. CZ-OPENSCREEN is sharing the know-how of high-throughput workflow for RNA isolation and preparation of RT-qPCR reactions, as well as the CORONAbase, with other academic institutions involved in Covid-19 testing, in order to improve their testing services and standards.

Czech BioImaging: Open Access support
Czech BioImaging , 16.04.2020
Czech Republic

In response to the COVID-19 pandemic, the National Research Infrastructure for Biological and Medical Imaging (Czech-BioImaging), as the Czech national node to the Euro-BioImaging ERIC pan-European network, offers prioritised access to Czech-BioImaging facilities with no fees attached for COVID-19 relevant scientific projects, selected for implementation within the ongoing call for the Czech-BioImaging Open Access support (July 2020 – June 2021). Deadline for submitting applications is 30th April 2020. More information and the application rules can be found at Czech-BioImaging website

CIEMAT-PSA: Facilities for water analysis and disinfection
CIEMAT-PSA, 15.04.2020

The Plataforma Solar de Almería (PSA), a dependency of CIEMAT, incorporates a fully equipped laboratory of water sample analysis, with a microbiology laboratory specialized in water disinfection provided also with DNA analysis by Real time PCR. The CIEMAT-PSA is not operating at this moment, however it will be in a short notice.

NANBIOSIS: Rapid access for biomedical product development
NANBIOSIS, 15.04.2020

The Infrastructure for the Production and Characterization of Nanomaterials, Biomaterials and Systems in Biomedicine (NANBIOSIS) provides rapid access for COVID-19 research. It offers preclinical stages services of biomedical product development. Specifically, synthesis and preparation of biomolecules like antibodies, peptides, recombinant proteins, oligonucleotides for diagnostic, therapeutic and prophylactic purposes.